[1] 陈旭, 苏士纹, 牛悦青. 过敏在中国的患病率及其对皮肤的影响——针对具有代表性的中国成年人群样本的流行病学研究[J]. 中华皮肤科杂志, 2021, 54(3):276-277. Chen X, Su SW,Niu YQ. Prevalence of allergies in China and its effects on skin - An epidemiological study of a representative sample of Chinese adults[J]. Chin J Dermatol, 2021, 54(3):276-277.(in Chinese) [2] 丁杨, 邱婷, 章恒. 301例婴幼儿湿疹影响因素分析[J]. 江苏医药, 2022, 48(6):606-608. Ding Y,Qiu T, Zhang H.An analysis of influencing factors for eczema in 301 infants[J]. Jiangsu Med J, 2022, 48(6):606-608.(in Chinese) [3] Hill DA, Spergel JM. The atopic march:Critical evidence and clinical relevance[J]. Ann Allergy Asthma Immunol, 2018, 120(2):131-137. [4] Langan SM, Irvine AD, Weidinger S. Atopic dermatitis[J]. Lancet, 2020, 396(10247):345-360. [5] Jain N. The early life education of the immune system:Moms, microbes and (missed) opportunities[J]. Gut Microbes, 2020, 12(1):1824564. [6] Borowczyk J, Shutova M, Brembilla NC, et al. IL-25 (IL-17E) in epithelial immunology and pathophysiology[J]. J Allergy Clin Immunol, 2021, 148(1):40-52. [7] Murdaca G, Greco M, Tonacci A, et al. IL-33/IL-31 axis in immune-mediated and allergic diseases[J]. Int J Mol Sci, 2019, 20(23):5856. [8] 中华医学会皮肤性病学分会免疫学组. 湿疹诊疗指南(2011年)[J]. 中华皮肤科杂志, 2011, 44(1):5-6. Immunology Group of Dermatology and Venereology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of eczema (2011)[J]. Chin J Dermatol, 2011, 44(1):5-6.(in Chinese) [9] 赵辨. 湿疹面积及严重度指数评分法[J]. 中华皮肤科杂志, 2004, 37(1):3-4. Zhao B. Eczema area and severity index scoring method[J]. Chin J Dermatol, 2004, 37(1):3-4.(in Chinese) [10] 岳和欣, 曲翌敏, 湛永乐, 等. 婴幼儿湿疹影响因素分析:一项五省市的前瞻性队列研究[J]. 中华疾病控制杂志, 2022, 26(9):1005-1010. Yue HX, Qu LM, Zhan YL, et al. Analysis of influencing factors of eczema in preschoolers in China:A prospective cohort study in five provinces[J]. Chin J Dis Control Prev, 2022, 26(9):1005-1010.(in Chinese) [11] Shi H, Wan G, Wang T, et al. Prevalence and influencing risk factors of eczema among preschool children in Urumqi city:A cross-sectional survey[J]. BMC Pediatr, 2021, 21(1):347. [12] Narla S, Silverberg JI. The role of environmental exposures in atopic dermatitis[J]. Curr Allergy Asthma Rep, 2020, 20(12):74. [13] 周琴, 古桂雄, 叶侃, 等. 婴儿湿疹发病相关因素分析[J]. 中国儿童保健杂志, 2019, 27(11):1240-1242. Zhou Q,Gu GX, Ye K, et al. Analysis on the influencing factors of infantile eczema[J]. Clin J Child Health Care, 2019, 27(11):1240-1242.(in Chinese) [14] Kader HA, Azeem M, Jwayed SA, et al. Current insights into immunology and novel therapeutics of atopic dermatitis[J]. Cells, 2021, 10(6):1392. [15] Patel NN, Kohanski MA, Maina IW, et al. Sentinels at the wall:Epithelial-derived cytokines serve as triggers of upper airway type 2 inflammation[J]. Int Forum Allergy Rhinol, 2019, 9(1):93-99. [16] Ricardo-Gonzalez RR, Van Dyken SJ, Schneider C, et al. Tissue signals imprint ILC2 identity with anticipatory function[J]. Nat Immunol, 2018, 19(10):1093-1099. [17] Borowczyk J, Shutova M, Brembilla NC, et al. IL-25 (IL-17E) in epithelial immunology and pathophysiology[J]. J Allergy Clin Immunol, 2021, 148(1):40-52. [18] Gamez C, Metcalfe J, Prescott SL, et al. Lower cord blood IL-17 and IL-25, but not other epithelial cell-derived cytokines are associated with atopic dermatitis in infancy[J]. Int Arch Allergy Immunol, 2021, 182(6):474-478. [19] Wang D, Beck LA. Immunologic targets in atopic dermatitis and emerging therapies:An update[J]. Am J Clin Dermatol, 2016, 17(5):425-443. [20] Ding W, Zou GL, Zhang W, et al. Interleukin-33:Its emerging role in allergic diseases[J]. Molecules, 2018, 23(7):1665. [21] Li C, Maillet I, Mackowiak C, et al. Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells[J]. Cell Death Dis, 2017, 8(4):e2735.. [22] Jaworek AK, Szafraniec K, Doniec Z, et al. Pruritus characteristics in severe atopic dermatitis in adult patients[J]. Adv Exp Med Biol, 2021,1289:71-77. [23] Ashley-Martin J, Dodds L, Arbuckle TE, et al. Predictors of interleukin-33 and thymic stromal lymphopoietin levels in cord blood[J]. Pediatr Allergy Immunol, 2015, 26(2):161-167. [24] Tamagawa-Mineoka R, Okuzawa Y, Masuda K, et al. Increased serum levels of interleukin 33 in patients with atopic dermatitis[J].J Am Acad Dermatol, 2014, 70(5):882-888. |